By Dr. David Caldwell, Founder of MiNDSET Integrative Ketamine Care
For decades, patients suffering from treatment-resistant depression (TRD), PTSD, anxiety, and chronic pain have faced a frustrating reality: traditional treatment options often fail to provide relief, and when they do, progress can be slow and incomplete. As an anesthesiologist with over 30 years of experience, I have witnessed both the promise and limitations of conventional medicine. At MiNDSET Integrative Ketamine Care, our mission is to accelerate healing by combining ketamine infusion therapy (KIT) with psychotherapy—an approach that achieves outcomes far beyond either treatment on its own.
The Case for Ketamine Infusion Therapy
Conventional antidepressants typically achieve a 40–47% response rate, with patients waiting 8–10 weeks before noticing significant changes. By contrast, ketamine therapy has consistently demonstrated a 65–70% response rate, with clinical improvement occurring within 24 hours of a single infusion. For one-third of TRD patients in published studies, remission can occur after just one treatment—a result unmatched by traditional pharmacology.
Safety data also show that at sub-anesthetic doses, ketamine is well-tolerated with no severe or lasting adverse effects, even after multiple treatments.
Why Integration Matters
While the neurochemical effects of ketamine can open a therapeutic window, its true potential emerges when paired with psychotherapy. Ketamine lowers psychological defenses, often dissolving the rigid mental frameworks that keep patients “stuck.” This creates an opportunity for deep therapeutic breakthroughs when guided by an experienced clinician.
At MiNDSET, every infusion is followed by a psychotherapy session—either with a patient’s existing therapist or with our in-house psychologist, Dr. Melissa Briggs-Phillips. This is not an optional add-on but a core element of our philosophy.
The result:
-
84% of our patients achieve meaningful improvement in symptoms.
-
1 in 10 patients achieve remission after their very first infusion, and many more reach remission by their third, fourth, or fifth treatment.
These outcomes highlight how integration accelerates and sustains healing.
Patient Stories: Lives Transformed
The numbers tell part of the story. The rest is best expressed by patients themselves.
-
One CPA with lifelong depression described ketamine-assisted therapy as bringing “peace.” His anxiety—once a constant negative feedback loop—was quiet. His depression—the “pit of despair”—was gone.
-
Another patient shared that after years of struggling, the immediate impact of treatment was “epiphanic.” They described feeling profoundly connected to existence, followed by a lasting sense of resilience and hope.
-
For patients with chronic pain conditions such as Complex Regional Pain Syndrome (CRPS), ketamine can “break the cycle of pain,” often restoring the ability to work and engage in daily life when other treatments have failed.
A Paradigm Shift in Mental Health Care
The integration of ketamine therapy and psychotherapy is more than just a treatment protocol—it represents a paradigm shift. By combining pharmacological innovation with psychological insight, we accelerate the healing process. What once took years of therapy or failed medications can now unfold in weeks.
At MiNDSET, we believe that healing happens when science and psychology meet, and our patient outcomes prove it.
Conclusion
The future of mental health treatment requires innovation grounded in evidence. Ketamine infusion therapy is one of the most promising breakthroughs in decades, but without integration, its potential is underutilized. By pairing ketamine with psychotherapy, MiNDSET is not just treating symptoms—we are restoring lives.
About the Author
Dr. David Caldwell is a board-certified anesthesiologist with over 30 years of clinical experience. He is the founder and medical director of MiNDSET Integrative Ketamine Care in Columbus, Ohio, where he leads a team dedicated to advancing patient outcomes through evidence-based integrative treatment.
